A major burden on children
Open Access
- 8 April 2008
- Vol. 336 (7650), 948.1-949
- https://doi.org/10.1136/bmj.39520.680718.94
Abstract
Resistance to drugs in many common childhood infections is a growing problem in the developing world, says Zulfiqar Bhutta. Effective programmes to combat resistance are within reach in developing countries, argue Ralph Gonzales and colleagues (doi: 10.1136/bmj.39534.553044.94), but we must move swiftlyKeywords
This publication has 9 references indexed in Scilit:
- Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programmeThe Lancet Infectious Diseases, 2008
- Failure of Chemoprophylaxis With Standard Antituberculosis Agents in Child Contacts of Multidrug-Resistant Tuberculosis CasesThe Pediatric Infectious Disease Journal, 2007
- In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric feverJournal of Medical Microbiology, 2007
- Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.The American Journal of Tropical Medicine and Hygiene, 2007
- Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort studyBMC Infectious Diseases, 2007
- Dealing with childhood pneumonia in developing countries: how can we make a difference?Archives of Disease in Childhood, 2007
- Hospital-acquired neonatal infections in developing countriesThe Lancet, 2005
- How many child deaths can we prevent this year?The Lancet, 2003
- THE MORTALITY CONSEQUENCES OF THE CONTINUED USE OF CHLOROQUINE IN AFRICA: EXPERIENCE IN SIAYA, WESTERN KENYAThe American Journal of Tropical Medicine and Hygiene, 2003